Trial
NCT01551446
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
Phase IWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Renal Insufficiency, Chronic
Intervention
Bardoxolone Methyl
Why stopped
IDMC recommendation for safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29